Repurposing atovaquone as a STAT3 inhibitor for the treatment of platinum resistant ovarian cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results